Andrea Assanelli Selected Research

Andrea Assanelli Research Topics

10	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2022 - 08/2015
5	Lymphoma (Lymphomas) 11/2015 - 04/2008
4	COVID-19 04/2022 - 01/2020
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 10/2014
3	Neoplasms (Cancer) 02/2023 - 05/2009
3	Infections 01/2020 - 12/2016
3	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2018 - 08/2013
2	Chronic Granulomatous Disease 11/2022 - 01/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 01/2022
2	Hematologic Neoplasms (Hematological Malignancy) 01/2020 - 12/2017
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2022
1	Liver Diseases (Liver Disease) 06/2021
1	Lung Injury 01/2020
1	Disease Progression 01/2020
1	Cytokine Release Syndrome 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Thalassemia 01/2019
1	Primary Myelofibrosis (Myelosclerosis) 09/2016
1	Splenomegaly 09/2016
1	Iron Overload 09/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2015
1	Pathologic Complete Response 08/2015
1	Neuromyelitis Optica (Devic's Disease) 03/2014
1	Lysosomal Storage Diseases (Lysosomal Storage Disease) 08/2013
1	Wiskott-Aldrich Syndrome 08/2013
1	Deficiency of Alpha Interleukin 2 Receptor 03/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2008
1	Hodgkin Disease (Hodgkin's Disease) 04/2008

5	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 11/2008
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 11/2015
3	Rituximab (Mabthera)FDA Link 01/2020 - 09/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 01/2020
2	Sirolimus (Rapamycin)FDA Link 01/2021 - 08/2015
2	treosulfanIBA 09/2016 - 08/2015
2	Cerebroside-Sulfatase (Arylsulfatase A)IBA 07/2016 - 08/2013
2	Etoposide (VP 16)FDA LinkGeneric 11/2015 - 09/2013
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	SteroidsIBA 10/2021
1	ruxolitinibIBA 10/2021
1	Angiotensin IIIBA 06/2021
1	CreatinineIBA 06/2021
1	CytokinesIBA 01/2020
1	Complement C3 (C3 Complement)IBA 01/2020
1	AMY-101IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020
1	compstatinIBA 01/2020
1	GlobinsIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	IronIBA 01/2019
1	defibrotideIBA 01/2018
1	fludarabineIBA 09/2016
1	Sorafenib (BAY 43-9006)FDA Link 06/2016
1	Pioglitazone (Actos)FDA Link 01/2016
1	AntimetabolitesIBA 11/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2015
1	Melphalan (Alkeran)FDA LinkGeneric 08/2015
1	Ifosfamide FDA LinkGeneric 09/2013
1	Proteins (Proteins, Gene)FDA Link 08/2013
1	Interleukin-2 (IL2)IBA 03/2013
1	2- (2- (1- phenyl- 4- piperazynyl)ethyl)- 1,2,3,4- tetrahydro- beta- carboline- 1- spiro- 4'- N'- benzylpiperidineIBA 04/2008

11	Hematopoietic Stem Cell Transplantation 11/2022 - 03/2014
6	Stem Cell Transplantation 01/2021 - 04/2008
4	Therapeutics 06/2021 - 05/2009
4	Drug Therapy (Chemotherapy) 09/2013 - 04/2008
3	Transplantation 01/2021 - 08/2015
2	Salvage Therapy 01/2022 - 09/2013
2	Homologous Transplantation 09/2016 - 10/2014
1	Palliative Care (Palliative Therapy) 02/2023
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 04/2022
1	Duration of Therapy 04/2022
1	Continuous Positive Airway Pressure 04/2022
1	Artificial Respiration (Mechanical Ventilation) 06/2021
1	Catheters 12/2017
1	Central Venous Catheters 12/2017
1	Haploidentical Transplantation 12/2016
1	Combination Drug Therapy (Combination Chemotherapy) 06/2009
1	Radiotherapy 06/2009